Medicamen Biotech Share price

MEDICAMEQ

Healthcare Small

271

4.20 (-1.53%)

NSE

BSE

Last updated on 13 Mar, 2026 | 15:29 IST

BUYSELL

Today's High

281.00

Today's Low

268.60

52 Week Low

268.60

52 Week High

544.00

Free Demat with Zero AMC*

Medicamen Biotech Chart

ChartIQ

TradingView

Medicamen Biotech Share Key Metrics

Volume

50782.00

Market Cap

373.25 CR

LTQ@LTP

3@271.00

ATP

274.37 Var Margin

21.95 %

Circuit Range

220.2-330.2

Delivery %

61.35 %

Value

1.39 CR

ASM/GSM

No

Market Lot

1

Summary

At 13 Mar, 2026 | 15:29, Medicamen Biotech share price stands at ₹271, showing a 4.20% -1.53 for the day. The stock’s intraday movement has stayed between ₹268.60 and ₹281.00, while on a 52-week basis it has fluctuated from ₹268.60 to ₹544.00.

In terms of trading activity, Medicamen Biotech has recorded a volume of 50782 shares, with a market capitalisation of ₹13562815. The stock’s Average Traded Price (ATP) stands at ₹27437, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3,27100. The stock operates within a circuit range of ₹220.2-330.2, with a Value of ₹1.39 CR. The Delivery Percentage for the day is 61.35%. Additionally, Medicamen Biotech currently falls under the No framework, and trades with a market lot size of 1.

Medicamen Biotech Fundamentals

P/E Ratio

40.02

P/B Ratio

1.4

Div. Yield

0.36

Sector P/E

60.72

Sector P/B

2.7

Sec. Div. Yield

0.58

Medicamen Biotech Resistance and Support

Pivot 277.25

Resistance

First Resistance

282.9

Second Resistance

290.6

Third Resistance

296.25

Support

First Support

269.55

Second Support

263.9

Third Support

256.2

Medicamen Biotech Futures & Options

Data Not Found

Medicamen Biotech Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26

Total Promoters

Segment

Percent

Total Promoters

42.99%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.06%

Domestic Institutional Investors

0.92%

Retail

56.04%

Others

-0.01%

Total Promoters

MAR '24

43.21%

JUN '24

42.99%

SEP '24

42.99%

DEC '24

42.99%

Medicamen Biotech Corporate Actions

Date	Agenda
2026-02-13	Quarterly Results
2025-11-14	Quarterly Results
2025-08-12	Quarterly Results
2025-05-30	Audited Results & Final Dividend
2025-02-26	Preferential issue of shares
2025-02-11	Quarterly Results

Medicamen Biotech News

Medicamen Biotech shares zoom 20%, up 40% in two sessions

Apr 29 2024 12:16:53

NSE : 6278

BSE : 531146

ISIN : INE646B01010

MBL was incorporated as a public limited company under the Companies Act 1956 on December 22 1993. The certificate of commencement of business was obtained on January 31 1994. The company has jointly been promoted by Mr.V.Kumar Mr.Bal Kishan Gupta Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh.MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst Cadila Hindustan Ciba Purepharma Oboi Labs etc. and exporting to countries like Germany Russia Holland CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales.MBL has obtained permission for production of tablets capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited New Delhi and Pure Pharma Private Limited Indore respectively.

Name	Position
Mr. Rahul Bishnoi	Chairman
Mr. Ashwani Kumar Sharma	Non Executive Director

Medicamen Biotech Similar Stocks

Kaya Ltd.

304.00

-9.15 (2.92%)

Nephro Care India Ltd.

68.95

-1.05 (1.50%)

Haleos Labs Ltd.

1262.00

0.00 (0.00%)

Par Drugs And Chemicals Ltd.

89.50

0.62 (0.70%)

Zim Laboratories Ltd.

66.51

1.84 (2.85%)

Medicamen Biotech FAQs

The Buying Price of Medicamen Biotech share is 271 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Medicamen Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Medicamen Biotech, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Medicamen Biotech shares is 40.02. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Medicamen Biotech shares is 1.4. Useful to assess the stock's value relative to its book value.

To assess Medicamen Biotech’s valuation compare Sector P/E, P/B which are 60.72 & 2.7 with sector averages, along with growth rates and financial metrics.

The Market Cap of Medicamen Biotech is 373.25 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Medicamen Biotech share price is 544.00 & 268.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Medicamen Biotech belongs to the Healthcare sector.